| Literature DB >> 27488346 |
Tomonori Takazawa1,2, Jou Ohta3, Tatsuo Horiuchi3, Hiroshi Hinohara4, Fumio Kunimoto4, Shigeru Saito3,4.
Abstract
BACKGROUND: Gas gangrene is a necrotic infection of soft tissue associated with high mortality rates. We report a case of postoperative gas gangrene with very acute onset and rapid progression of symptoms. To our knowledge, this case is the most acute onset of postoperative gas gangrene ever reported. CASEEntities:
Keywords: Clostridium perfringens; Gas gangrene; Postoperative
Mesh:
Year: 2016 PMID: 27488346 PMCID: PMC4973043 DOI: 10.1186/s13104-016-2194-0
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Vital signs of the patient on the day of and after the surgery. The black and brown lines indicate systolic and diastolic blood pressure, respectively. Closed circles and open squares indicate body temperature and heart rate, respectively. DOA dopamine hydrochloride
Fig. 2Images of the patient. a A diffuse skin rash developed over the left side of her trunk 2 days after the surgery. b Abdominal X-ray taken immediately after ICU admission showed soft tissue swelling with the density of air on the left abdominal wall (arrows). c Computed tomography of the abdomen taken 2 days after the surgery showed subcutaneous emphysema over the left side of the trunk (arrows). d Enhanced computed tomography of the abdomen taken 1 day after the surgery. The rectangle indicates the area shown in e. e The arrows indicate air-densities between the subcutaneous fat tissue and muscle layer in the vicinity of the left drainage tube
Results of blood tests performed immediately after ICU admission
| Blood count | |
| Hct (%) | 28.5 |
| Hb (g/dl) | 9.2 |
| WBC (/μl) | 7500 |
| Plt (/μl) | 7.1 × 104 |
| Blood coagulation tests | |
| PT (%) | 37 |
| APTT (s) | 59.3 |
| Fibrinogen (mg/dl) | 385 |
| FDP (μg/ml) | 47.3 |
| | 39.1 |
| TAT (ng/ml) | 36.1 |
| PIC (μg/ml) | 1.3 |
| Biochemical tests | |
| T-bil (mg/dl) | 6.2 |
| AST (IU/l) | 376 |
| ALT (IU/l) | 41 |
| LDH (IU/l) | 3067 |
| BUN (mg/dl) | 49 |
| Cr (mg/dl) | 2.23 |
| CRP (mg/dl) | 24.24 |
| Blood gas analysis | |
| pH | 7.265 |
| pCO2 | 14.3 |
| pO2 (FM 8L) | 91.7 |
| HCO3 − (mmol/l) | 10.5 |
| BE (mmol/l) | −20.6 |
Hct hematocrit, Hb hemoglobin, WBC white blood cells, Plt platelets, PT prothrombin time, APTT activated partial thromboplastin time, FDP fibrin/fibrinogen degradation products, TAT thrombin-antithrombin complex, PIC plasmin-α2 plasmin inhibitor complex, T-bil total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, BUN blood urea nitrogen, Cr creatinine, CRP C-reactive protein, pCO carbon dioxide partial pressure, pO oxygen partial pressure, BE base excess
Fig. 3The clinical course of the patient. FOM fosfomycin, ISP isepamicin, IPM/CS imipenem/cilastatin, CLDM clindamycin, VCM vancomycin, FCZ fluconazole, CPFX ciprofloxacin, MEPM meropenem, CAZ ceftazidime, HBOT hyperbaric oxygen therapy, HD hemodialysis, CHDF continuous hemodiafiltration, APACHE acute physiology and chronic health evaluation, SOFA sequential organ failure assessment
List of the bacteria that were isolated and results of antimicrobial susceptibility testing
| Species | Bacteria count | Sampling site | Date of collection | Reporting date | Antimicrobial susceptibility testing | ||
|---|---|---|---|---|---|---|---|
| Susceptible | Intermediate | Resistant | |||||
|
| 2+ | Closed abscess | POD2 | POD6 | ABPC, ABPC/SBT, CMZ, FMOX, IPM, MINO | LVFX | CLDM |
| Small number | Drain | POD2 | POD9 | ABPC/SBT, IPM, MINO | ABPC, CMZ, FMOX, LVFX | CLDM | |
|
| 3+ | Debris | POD14 | POD17 | PIPC, CPZ, CAZ, CZOP, CFS, CFPM, MEPM, AZT, S/C, TOB, AMK, LVFX, CPFX | IPM, GM | FOM |
| 3+ | Open abscess | POD24 | POD28 | ||||
|
| 3+ | Open abscess | POD33 | POD38 | PIPC, CAZ, CZOP, S/C, TOB, AMK | CPZ, CFS, CFPM, GM | IPM, MEPM, AZT, LVFX, CPFX, FOM |
|
| 2+ | Debris | POD14 | POD17 | N/A | N/A | N/A |
| 2+ | Open abscess | POD24 | POD28 | N/A | N/A | N/A | |
|
| N/A | CV catheter | POD8 | POD15 | VCM, TEIC, LZD | N/A | PCG, ABPC, MPIPC, CEZ, CTM, CPR, FMOX, IPM, GM, EM, CLDM, LVFX, ST, FOM |
| N/A | Venous blood, CV catheter | POD14 | POD17 | VCM, TEIC | N/A | PCG, ABPC, MPIPC, CEZ, CTM, CPR, FMOX, IPM, GM, EM, CLDM, LVFX, ST, FOM | |
|
| 3+ | Open abscess | POD24 | POD28 | MINO, ST | LVFX | CAZ |
| 3+ | Open abscess | POD33 | POD38 | MINO, ST | N/A | CAZ, LVFX | |
|
| 3+ | Open abscess | POD33 | POD38 | VCM, TEIC, LZD | N/A | LVFX, ABPC, PCG, EM |
POD post-operative days, ABPC ampicillin, ABPC/SBT ampicillin/sulbactam, CMZ cefmetazole, FMOX flomoxef, IPM imipenem, MINO minocycline, PIPC piperacillin, CPZ cefoperazone, CAZ ceftazidime, CZOP cefozopran, CFS cefsulodin, CFPM cefepime, MEPM meropenem, AZT aztreonam, S/C sulbactam/cefoperazone, TOB tobramycin, AMK amikacin, LVFX levofloxacin, VCM vancomycin, TEIC teicoplanin, LZD linezolid, ST sulfamethoxazole–trimethoprim, GM gentamicin, CLDM clindamycin, FOM fosfomycin, CPFX ciprofloxacin, PCG benzylpenicillin, MPIPC oxacillin, CEZ cephazolin, CTM cefotiam, CPR cefpirome, EM erythromycin